4//SEC Filing
NANOVIRICIDES, INC. 4
Accession 0001144204-16-082885
$NNVCCIK 0001379006operating
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 7:02 PM ET
Size
13.0 KB
Accession
0001144204-16-082885
Insider Transaction Report
Form 4
BONIUK MILTON
Director
Transactions
- Award
Common Stock, par value $0.001 per share
2016-02-08$1.40/sh+9,000$12,600→ 159,000 total(indirect: By IRA) - Award
Common Stock, par value $0.001 per share
2016-02-10$1.36/sh+9,000$12,240→ 168,000 total(indirect: By IRA) - Award
Common Stock, par value $0.001 per share
2016-02-12$1.18/sh+34,043$40,171→ 976,902 total(indirect: Held by Boniuk Interests Ltd.) - Award
Common Stock, par value $0.001 per share
2016-02-12$1.18/sh+34,043$40,171→ 605,474 total(indirect: By Foundation) - Award
Common Stock, par value $0.001 per share
2016-02-12$1.18/sh+141,844$167,376→ 309,844 total(indirect: By IRA)
Footnotes (4)
- [F1]Represents the price of shares issued upon conversion of quarterly interest in the amount of $40,000 payable pursuant to a previously issued debenture.
- [F2]Does not include: 952,381 shares of Common Stock issuable upon conversion of a 10% Coupon Series C Convertible Debenture, or 187,000 shares of Series A Preferred Stock held by Milton Boniuk IRA, convertible into 654,500 shares of common stock, which are not readily convertible; 1,133,963 shares of Common Stock and warrants to purchase an additional 571,428 shares of Common Stock held by the Reporting Person and his wife; warrants to purchase an additional 285,714 shares of Common Stock or an indeterminate number of shares of Common Stock issuable upon conversion of debentures held by Boniuk Interests, Ltd.; or 605,474 shares of Common Stock held by the Boniuk Charitable Foundation. Dr. Boniuk holds voting and dispositive power over the Boniuk Charitable Foundation, Boniuk Interests Ltd. and the Milton Boniuk IRA.
- [F3]Represents the price of shares issued upon conversion of quarterly interest in the amount of $40,000 payable pursuant to a previously issued debenture.
- [F4]Represents the price of shares issued upon conversion of quarterly interest in the amount of $166,666.67 payable pursuant to a previously issued debenture.
Documents
Issuer
NANOVIRICIDES, INC.
CIK 0001379006
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001379006
Filing Metadata
- Form type
- 4
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 7:02 PM ET
- Size
- 13.0 KB